Pharmacokinetics of topical Ciprodex
otic suspension in pediatric and adolescent patients after tympanostomy tube surgery.
Otic Suspension is the only topical combination antibiotic/corticosteroid drug product approved by the United States Food and Drug Administration (FDA) for the treatment of external and middle ear infections and is the most widely prescribed branded eardrop by pediatricians and ear, nose and throat specialists in the U.
Otic topical drops have been approved for patients 6 months of age and older.
The FDA also approved Ciprodex
Otic for the topical treatment of acute otitis externa (AOE), a common ear infection also known as swimmer's ear.
Best Use of Direct Marketing to Healthcare Professionals to Alcon Labs and MTI for Ciprodex
eXtendRx Sales Optimization Program, with an honorable mention to Baxter BioScience and The Hamilton Communications Group for Advate Camp Superfly launch